/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

AMPH — Amphastar Pharmaceuticals, Inc.

Nasdaq

Amphastar Pharmaceuticals, Inc.

Back to Screener
$25.43
+0.08(+0.32%)
O
25.46
H
25.55
L
25.06
V
372.33K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Amphastar Pharmaceuticals, Inc. Statistics

Total Valuation

Market Cap$1.11B
Enterprise Value$1.16B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding42.54M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio181.64
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio13.97
P/TBV Ration/a
P/FCF Ratio29.00
P/OCF Ratio27.13
PEG Ration/a

Enterprise Valuation

EV / Earnings180.98
EV / Salesn/a
EV / EBITDA35.11
EV / EBIT69.97
EV / FCF30.31

Financial Position

Current Ratio3.85
Quick Ration/a
Debt / Equity0.87
Debt / EBITDA2.04
Debt / FCF1.76
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)8.30%
Return on Assets (ROA)3.90%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$3,249
Employee Count1,976
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$3.63M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-4.11%
50-Day Moving Average$22.47
200-Day Moving Average$22.35
Relative Strength Index (RSI)60.27
Average Volume (20 Days)550,555

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$70.32M
Operating Income$13.63M
Pretax Income$10.05M
Net Income$6.42M
EBITDA$33.10M
EBIT$16.61M
Earnings Per Share$0.14

Balance Sheet

Cash & Cash Equivalents$17.09M
Total Debt$67.50M
Net Cash-$50.41M
Net Cash Per Share$-1.18
Equity (Book Value)$77.34M
Book Value Per Share$1.82
Working Capital$46.92M

Cash Flow

Operating Cash Flow$40.98M
Capital Expenditures-$9.51M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$38.33M
FCF Per Share$0.90

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield0.55%
FCF Yield3.45%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$2.10
Lynch Upside-91.74%
Graham Number$2.39
Graham Upside-90.60%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a